MYL6P2

Across TCGA pan-cancer cohorts, MYL6P2 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated MYL6P2 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher MYL6P2 RNA is associated with better overall survival. In most high-consensus cancer types, elevated MYL6P2 expression acts as an unfavorable survival marker, although some lineages such as COAD and UCS show a favorable association.

COAD, UCS, and ACC are the cancer types where MYL6P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.928	0.811	.001	46	view →
UCS	DFS	Quartile	II,III,IV	0.582	0.171	.017	32	view →
ACC	OS	Median	II,III,IV	0.436	0.708	.004	28	view →
CHOL	OS	Tertile	II,III,IV	0.024	0.601	.025	27	view →
OV	DFS	Quartile	IV	0.692	0.334	.002	22	view →
KIRP	DFS	Tertile	III,IV	0.933	0.613	.016	17	view →
THCA	DFS	Tertile	All	0.923	0.799	.003	17	view →
MESO	DFS	Quartile	III,IV	0.616	0.336	.026	9	view →
READ	OS	Quartile	IV	0.352	1.000	.019	9	view →
THYM	DFS	Quartile	All	1.000	0.595	.028	8	view →
LGG	OS	Median	All	0.767	0.846	.013	8	view →
KICH	DFS	Quartile	II,III,IV	0.632	0.918	.022	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

MYL6P2–COAD (OS)

Open the COAD breakdown →